- Home
- TPIC vs ONCY Comparison
TPIC vs ONCY Comparison
Compare TPIC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPIC
- ONCY
- Stock Information
- Founded
- TPIC 1968
- ONCY 1998
- Country
- TPIC United States
- ONCY Canada
- Employees
- TPIC N/A
- ONCY N/A
- Industry
- TPIC Industrial Machinery/Components
- ONCY Pharmaceuticals and Biotechnology
- Sector
- TPIC Industrials
- ONCY Health Care
- Exchange
- TPIC Nasdaq
- ONCY Nasdaq
- Market Cap
- TPIC 58.4M
- ONCY 49.1M
- IPO Year
- TPIC 2016
- ONCY 1999
- Fundamental
- Price
- TPIC $1.15
- ONCY $0.69
- Analyst Decision
- TPIC Hold
- ONCY Strong Buy
- Analyst Count
- TPIC 6
- ONCY 4
- Target Price
- TPIC $1.82
- ONCY $4.33
- AVG Volume (30 Days)
- TPIC 616.9K
- ONCY 1.4M
- Earning Date
- TPIC 08-07-2025
- ONCY 07-31-2025
- Dividend Yield
- TPIC N/A
- ONCY N/A
- EPS Growth
- TPIC N/A
- ONCY N/A
- EPS
- TPIC N/A
- ONCY N/A
- Revenue
- TPIC $1,373,242,000.00
- ONCY N/A
- Revenue This Year
- TPIC $10.66
- ONCY N/A
- Revenue Next Year
- TPIC $6.52
- ONCY N/A
- P/E Ratio
- TPIC N/A
- ONCY N/A
- Revenue Growth
- TPIC 3.05
- ONCY N/A
- 52 Week Low
- TPIC $0.64
- ONCY $0.33
- 52 Week High
- TPIC $5.26
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- TPIC 52.99
- ONCY 69.96
- Support Level
- TPIC $1.06
- ONCY $0.56
- Resistance Level
- TPIC $1.26
- ONCY $0.37
- Average True Range (ATR)
- TPIC 0.11
- ONCY 0.07
- MACD
- TPIC -0.02
- ONCY 0.04
- Stochastic Oscillator
- TPIC 47.11
- ONCY 83.26
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.